Article
Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution
4 Dec 2017
Abstract excerpt
Intra-tumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease recurrence, and is a read-out of tumor growth. Current genetic ITH analysis methods do not preserve spatial context and may not detect rare subclones. Here, we address these shortfalls by developing and validating BaseScope-a novel mutation-specific RNA in situ hybridization assay. We target common point mutations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
